Connect with us

Company News

Honeywell’s Quantinuum valued at $17.6B as shares rise in Nasdaq debut

Shares of Quantinuum rose 13.3% in their Nasdaq debut, fetching a valuation of $17.63 billion as Honeywell’s quantum computing company became ‌the latest to benefit from robust investor demand.

The stock opened at $68, compared with its IPO price of $60.

Breakthroughs in the fast-growing technology have spurred bets that quantum machines could eventually outperform conventional computers on certain complex tasks. Quantinuum, like its rival IonQ, makes machines that hit trapped ions with lasers to perform quantum computations, where data can be either 1 ​or a 0, as with conventional computers, or both a 1 and a 0 at once.

“We, in working with our customers, now ​have a very clear view that quantum is not still years away. The commercialization has started – started small, but ⁠exhilarating,” Quantinuum CEO Raj Hazra told Reuters in an interview. “We believe we are ready for public markets.”

However, investors remain cautious about the industry’s ability ​to generate sustainable commercial revenue in the near term.

Sentiment in the sector has also been buoyed after the U.S. government last month announced a $2 billion initiative ​to take equity stakes in nine quantum computing companies, including a planned $100 million investment in Quantinuum.

“The investment case is centered on the long-term potential of quantum computing and its potential role in future computing infrastructure,” IPOX Schuster analyst Kat Liu said. “The support is meaningful because quantum computing is increasingly viewed as a strategic technology with implications for ​national security, AI, communications and advanced computing.”

The sector has also drawn investor interest as increasingly sophisticated and resource-intensive AI systems fuel expectations that demand ​for quantum computers could eventually gain traction.

As of Wednesday’s close, shares of peer IonQ have surged about 52% this year, giving the company a market value of about $25.47 ‌billion, according ⁠to LSEG data.

The Broomfield, Colorado-based company raised $1.68 billion in an upsized IPO by selling 28 million shares at $60 each, above its marketed range of $53 to $55 per share. The company earlier this week raised the number of shares on sale to 26.5 million.

The debut comes as the U.S. new listings market regains impetus, although investor appetite remains concentrated in technology and other high-growth sectors.

Founded in 2021 through the merger of quantum computing operations of ​Honeywell and software specialist Cambridge Quantum, ​Quantinuum develops quantum hardware and ⁠software systems designed to solve complex computational problems.

“Quantinuum also benefits from Honeywell’s backing and has expanded beyond hardware into software, cybersecurity, and quantum networking applications. Commercial adoption remains limited, but investors are primarily buying into the long-term opportunity,” ​Liu said.

Honeywell will own about 48.1% of the combined voting power in the company upon completion of the ​offering, Quantinuum said ⁠in a regulatory filing.

Still, Quantinuum’s commercial revenue remains highly concentrated.

Japan’s RIKEN research institute accounted for roughly 60% of the company’s 2025 revenue, highlighting the industry’s continued reliance on government and research spending.

For full-year 2025, Quantinuum had sales of $30.9 million and a net loss of $192.6 million.

Edward Best, a partner at Willkie Farr & Gallagher, said ⁠investors should ​monitor whether the company broadens its customer base and increases the number and value of ​commercial contracts over time.

The industry also continues to grapple with high development costs, technological complexity and an uncertain timeline for widespread commercial adoption.

J.P. Morgan and Morgan Stanley were the lead active ​book-running managers for the offering. Reuters

Click to comment

You must be logged in to post a comment Login

Leave a Reply

Copyright © 2026 Communications Today maintained by Algocept

error: Content is protected !!